164 related articles for article (PubMed ID: 33029508)
21. Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin.
Yang H; Zhou X; Liu X; Yang L; Chen Q; Zhao D; Zuo J; Liu W
Biochem Biophys Res Commun; 2011 Jun; 410(1):114-20. PubMed ID: 21640711
[TBL] [Abstract][Full Text] [Related]
22. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
23. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
Zuo L; Motherwell MS
Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
[TBL] [Abstract][Full Text] [Related]
24. [The role of parkin in Parkinson's disease].
Miklya I; Göltl P; Hafenscher F; Pencz N
Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
[TBL] [Abstract][Full Text] [Related]
25. Parkin and PINK1 functions in oxidative stress and neurodegeneration.
Barodia SK; Creed RB; Goldberg MS
Brain Res Bull; 2017 Jul; 133():51-59. PubMed ID: 28017782
[TBL] [Abstract][Full Text] [Related]
26. DJ-1 mediates paraquat-induced dopaminergic neuronal cell death.
Kwon HJ; Heo JY; Shim JH; Park JH; Seo KS; Ryu MJ; Han JS; Shong M; Son JH; Kweon GR
Toxicol Lett; 2011 Apr; 202(2):85-92. PubMed ID: 21300143
[TBL] [Abstract][Full Text] [Related]
27. Twenty years since the discovery of the parkin gene.
Hattori N; Mizuno Y
J Neural Transm (Vienna); 2017 Sep; 124(9):1037-1054. PubMed ID: 28620835
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines.
Shaltouki A; Sivapatham R; Pei Y; Gerencser AA; Momčilović O; Rao MS; Zeng X
Stem Cell Reports; 2015 May; 4(5):847-59. PubMed ID: 25843045
[TBL] [Abstract][Full Text] [Related]
29. Curcumin Rescues a PINK1 Knock Down SH-SY5Y Cellular Model of Parkinson's Disease from Mitochondrial Dysfunction and Cell Death.
van der Merwe C; van Dyk HC; Engelbrecht L; van der Westhuizen FH; Kinnear C; Loos B; Bardien S
Mol Neurobiol; 2017 May; 54(4):2752-2762. PubMed ID: 27003823
[TBL] [Abstract][Full Text] [Related]
30. N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.
Eldeeb MA; Ragheb MA
Curr Genet; 2020 Aug; 66(4):693-701. PubMed ID: 32157382
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations.
González-Casacuberta I; Juárez-Flores DL; Ezquerra M; Fucho R; Catalán-García M; Guitart-Mampel M; Tobías E; García-Ruiz C; Fernández-Checa JC; Tolosa E; Martí MJ; Grau JM; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G
Aging (Albany NY); 2019 Jun; 11(11):3750-3767. PubMed ID: 31180333
[TBL] [Abstract][Full Text] [Related]
32. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
Pinto M; Nissanka N; Moraes CT
J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
[No Abstract] [Full Text] [Related]
33. Structural analysis of the effects of mutations in Ubl domain of Parkin leading to Parkinson's disease.
Biswas S; Roy R; Biswas R; Bagchi A
Gene; 2020 Feb; 726():144186. PubMed ID: 31647998
[TBL] [Abstract][Full Text] [Related]
34. Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10.
McCarthy S; Somayajulu M; Sikorska M; Borowy-Borowski H; Pandey S
Toxicol Appl Pharmacol; 2004 Nov; 201(1):21-31. PubMed ID: 15519605
[TBL] [Abstract][Full Text] [Related]
35. Parkin loss-of-function pathology: Premature neuronal senescence induced by high levels of reactive oxygen species?
Buhlman LM
Mech Ageing Dev; 2017 Jan; 161(Pt A):112-120. PubMed ID: 27374431
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast Biomarkers of Sporadic Parkinson's Disease and LRRK2 Kinase Inhibition.
Smith GA; Jansson J; Rocha EM; Osborn T; Hallett PJ; Isacson O
Mol Neurobiol; 2016 Oct; 53(8):5161-77. PubMed ID: 26399642
[TBL] [Abstract][Full Text] [Related]
37. Leukocyte glucocerebrosidase and β-hexosaminidase activity in sporadic and genetic Parkinson disease.
Kim HJ; Jeon B; Song J; Lee WW; Park H; Shin CW
Parkinsonism Relat Disord; 2016 Feb; 23():99-101. PubMed ID: 26705847
[TBL] [Abstract][Full Text] [Related]
38. Altered oxidative stress levels in Indian Parkinson's disease patients with PARK2 mutations.
Vinish M; Anand A; Prabhakar S
Acta Biochim Pol; 2011; 58(2):165-9. PubMed ID: 21584286
[TBL] [Abstract][Full Text] [Related]
39. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
Koentjoro B; Park JS; Sue CM
Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
[TBL] [Abstract][Full Text] [Related]
40. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
Jiang H; Ren Y; Zhao J; Feng J
Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
